Jim Simons Bluebird Bio, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 791,504 shares of BLUE stock, worth $300,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
791,504
Previous 2,187,700
63.82%
Holding current value
$300,771
Previous $2.8 Million
72.32%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BLUE
# of Institutions
159Shares Held
79.7MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$5.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$3.91 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$2.43 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$1.96 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.77 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $29.3M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...